Irish oncology app launches search engine for clinical trials


Irish apps company ONCOassist has launched a clinical trials search engine in partnership with clinical trials organization Cancer Trials Ireland.

The search engine function will be added to the ONCOassist app, which allows oncology clinicians to access relevant and up-to-date tools and content through their smart devices.

Huge demand for a search engine tool has been identified through engagement with the company’s community of over 13,000 users in 170 countries and close collaboration with Cancer trials in Ireland.

The search engine was funded by €25,000 from the Health Service Executive, which provides Irish public health services in hospitals and the community. The amount was awarded under the QIC Digital Innovation Program, which is designed to open innovation pathways for clinicians to seek seed funding for creative digital solutions.

Other features of the ONCOassist app include adjuvant tools, formulas, prognostic scores, common toxicity criteria for adverse events, medication information, and a medication intervention checker.

The clinical trials search engine is now available across Ireland and aims to expand globally.


With over 70 active cancer trials currently in Ireland, this tool aims to make finding trials and participants easier for oncology healthcare professionals.

Traditionally, trials are announced on the website, which lists privately and publicly funded studies conducted around the world, but ONCOassist says that often the information in the database is outdated or incomplete.

The search engine aims to make it easier to find trials by reducing the amount of study costs spent on recruiting patients to participate in trials, making it easier to refer patients to trials by including site-specific information and raise awareness of under-registered trials.


Oncology-focused platforms have become increasingly popular in the digital health space. In July, a UK cancer-focused tech startup Vine health announced that seed funding of £1.2 million would be used to develop its platform.

Finnish health data science start-up Kaiku Health recently teamed up with Amgen to partner with a digital symptom tracker for multiple myeloma, a type of bone marrow cancer.

Meanwhile, the American artificial intelligence (AI) platform technology company Precision Health AI recently announced a new platform, called Eureka Health Oncology, which uses electronic medical record (EMR) data to provide practical applications of AI for real-world oncology use cases.


ONCOassist co-founder and CEO Eoin O’Carroll said: “We are constantly striving to contribute to the cancer care community in Ireland and overseas, and the new engine does just that. clinical trial research. By identifying this need, we are able to collaborate with our peers to bring a solution-focused approach that improves cancer patient care.

Source link


Comments are closed.